Centered On Patient Needs, Guided By Clinical Value, And Driven By Research And Development Innovation
20 Years Of Continuous Focus On Exploring And Discovering The Pharmacological Effects Of Molecular Level Substances In Ginkgo Biloba
Based In China, Benefiting The World
We Are Willing To Seek Strategic Partners Globally To Jointly Develop, Commercialize, And License Our Innovative Assets With Independent Intellectual Property Rights Worldwide.
Innovative Drugs Are The Only Business We Develop, And We Are Committed To Sincerely Cooperating With Industry Elites From All Over The World To Bring The Highest Quality And Most Innovative Therapies To Doctors And Patients. We Choose Like-minded Partners, Adhere To The Concept Of "patient-centered" And "pragmatic, Altruistic", And Transform "effective Drugs And Conscience Drugs" Into Benefits For Patients.
Baiyu Pharmaceutical Regards Internationalization As An Important Development Strategy For The Company, Actively Promoting The Modernization And Internationalization Of Traditional Chinese Medicine. Ginkgo Biloba Innovative Drugs, Represented By Ginkgolide Injection, Have Brought New Treatment Options For Stroke Patients. They Have Been Registered In Southeast Asian Countries Such As Vietnam And Malaysia, And Actively Expanded Into Emerging Markets Such As Brazil, Chile, Peru, And Mexico.